P16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi. (22nd January 2014)

• Record Type: Journal Article
• Authors: Chang, Laura M.; Cassarino, David S.
• Other Names: Clelia M. Academic Editor.; Feinmesser M. Academic Editor.; Quatresooz P. Academic Editor.
• Is Part Of: ISRN dermatology. Volume 2014(2014)
• Publication Date: 2014-01-22
• Subjects: Dermatology -- Periodicals; Skin Diseases; Dermatology; Dermatology; Periodicals; 616.5
• DOI: 10.1155/2014/348417
• Languages: English
• ISSNs: 2090-4592

Abstract

Abstract : Background . Significant decreases in p16 expression have been shown to occur in melanoma compared to Spitz tumors, and loss of p16 staining has been found to correlate with melanoma tumor progression. However, comparison of p16 between atypical cellular blue nevi (CBN) and melanoma has not been reported previously. Methods . p16 immunohistochemical staining was evaluated in 14 atypical CBN, 8 conventional and atypical melanocytic nevi, and 16 melanomas, including 4 malignant CBN. p16 staining intensity was graded on a scale of 0–3 and the percentage of melanocytes stained with p16 was determined. Results . p16 staining was significantly higher in all CBN as a group when compared to melanomas (P = 0.001 ) and malignant CBN (P = 0.00008 ). Higher p16 expression was also seen in mildly (P = 0.0002 ) and moderately atypical (P = 0.02 ), but not severely atypical, CBN compared to melanomas. Conclusions . p16 immunohistochemical expression is higher in mildly and moderately atypical CBN compared to severely atypical CBN and melanomas. In conjunction with additional markers and histology, p16 staining may be useful in confirming the benign nature of these tumors, but is not useful in distinguishing severely atypical CBN from malignant cases, consistent with the overlapping histologic features between these tumors.